论文部分内容阅读
Pharmacometricians are often constrained in what types of mathematical constructs they may apply to modeling drug efficacy and safety.Current scientific frameworks limit models to sets of algebraic and/or differential equations yet many questions arise in tumor modeling that simply cannot be answered by the current paradigm.